Evaluation of a Novel Cystoscopic Compatible Cryocatheter for the Treatment of Bladder Cancer
Evaluation of a Novel Cystoscopic Compatible Cryocatheter for the Treatment of Bladder Cancer
复制标题
DOI:
10.3233/blc-200321
复制
发表时间:
2020-01-01
期刊:
影响因子:
1.1
通讯作者:
Baust, John G.
中科院分区:
文献类型:
--
作者:
Baust, John M.;Robilotto, Anthony;Baust, John G.
BACKGROUND: As the acceptance of cryoablative therapies for the treatment of non-metastatic cancers continues to grow, avenues for novel cryosurgical technologies and approaches have opened. Within the field of genitourinary tumors, cryosurgical treatments of bladder cancers remain largely investigational. Current modalities employ percutaneous needles or transurethral cryoballoons or sprays, and while results have been promising, each technology is limited to specific types and stages of cancers.OBJECTIVE: This study evaluated a new, self-contained transurethral cryocatheter, FrostBite-BC, for its potential to treat bladder cancer.METHODS: Thermal characteristics and ablative capacity were assessed using calorimetry, isothermal analyses, in vitro 3-dimensional tissue engineered models (TEMs), and a pilot in vivo porcine study.RESULTS: Isotherm assessment revealed surface temperatures below -20 degrees C within 9 sec. In vitro TEMs studies demonstrated attainment of = 30 sec full thickness ablation of the bladder wall.CONCLUSIONS: These studies demonstrate the potential of the FrostBite-BC cryocatheter as a treatment option for bladder cancer. Although preliminary, the outcomes of these studies were encouraging, and support the continued investigation into the potential of the FrostBite-BC cryocatheter as a next generation, minimally invasive cryoablative technology.